Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA38902
Max Phase: Preclinical
Molecular Formula: C19H25N6O7P
Molecular Weight: 480.42
Molecule Type: Small molecule
Associated Items:
ID: ALA38902
Max Phase: Preclinical
Molecular Formula: C19H25N6O7P
Molecular Weight: 480.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)NC(CCP(=O)(O)O)C(=O)O)cc1)C2
Standard InChI: InChI=1S/C19H25N6O7P/c20-19-24-15-13(17(27)25-19)7-10(9-22-15)8-21-12-3-1-11(2-4-12)16(26)23-14(18(28)29)5-6-33(30,31)32/h1-4,10,14,21H,5-9H2,(H,23,26)(H,28,29)(H2,30,31,32)(H4,20,22,24,25,27)
Standard InChI Key: SGOILMDABCVEJA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 480.42 | Molecular Weight (Monoisotopic): 480.1522 | AlogP: 0.21 | #Rotatable Bonds: 9 |
Polar Surface Area: 220.02 | Molecular Species: ACID | HBA: 9 | HBD: 8 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.80 | CX Basic pKa: 4.17 | CX LogP: -2.82 | CX LogD: -6.39 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.23 | Np Likeness Score: -0.05 |
1. Rosowsky A, Forsch RA, Reich VE, Freisheim JH, Moran RG.. (1992) Side chain modified 5-deazafolate and 5-deazatetrahydrofolate analogues as mammalian folylpolyglutamate synthetase and glycinamide ribonucleotide formyltransferase inhibitors: synthesis and in vitro biological evaluation., 35 (9): [PMID:1578484] [10.1021/jm00087a012] |
Source(1):